ASBPW

Aspire Biopharma Warrant
ASBPW

36 hedge funds and large institutions have $7.27M invested in Aspire Biopharma Warrant in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.1M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.4M
2
+$1.5M
3
+$179K
4
SCM
Saba Capital Management
New York
+$157K
5
LA
Linden Advisors
New York
+$144K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$12K
27
$8K
28
$6K
29
$4K
30
$4K
31
$4K
32
$3K
33
$3K
34
$2.63K
35
$2K
36
$3
1
2